Results 151 to 160 of about 312,196 (386)

Hypoxic Cell Waves around Necrotic Cores in Glioblastoma: A Biomathematical Model and its Therapeutic Implications

, 2012
Glioblastoma is a rapidly evolving high-grade astrocytoma that is distinguished pathologically from lower grade gliomas by the presence of necrosis and microvascular hiperplasia.
Calvo, Gabriel F., Martínez-González, Alicia, Pérez-García, Víctor M., Romasanta, Luis A. Pérez   +3 more
core   +1 more source

Desoxyribonucleoprotein Thromboembolism Following Total Body Irradiation: Case Report [PDF]

, 1960
Z. Hruban, Mila Pierce, Sumati Nair, Nancy E. Warner   +3 more
openalex   +1 more source

American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism.

Blood Advances, 2018
BACKGROUND Despite an increasing incidence of venous thromboembolism (VTE) in pediatric patients in tertiary care settings, relatively few pediatric physicians have experience with antithrombotic interventions.
P. Monagle, Carlos A. Cuello, Caitlin Augustine, M. Bonduel, L. Brandão, Tammy Capman, Anthony K. C. Chan, S. Hanson, C. Male, J. Meerpohl, F. Newall, S. O’Brien, L. Raffini, Heleen van Ommen, J. Wiernikowski, Suzan Williams, Meha Bhatt, J. Riva, Y. Roldán, N. Schwab, R. Mustafa, S. Vesely   +21 more
semanticscholar   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Puerperal Thromboembolism in Relation to the Inhibition of Lactation by Oestrogen Therapy [PDF]

, 1968
T. N. A. Jeffcoate, Joseph M. Miller, Reinhard Roos, V. R. Tindall   +3 more
openalex   +1 more source

Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu, Qiuhong Zhang, Jie Gao, Shiyuan Yao, Chan Tian, Tuo He, Ming Zhang, Hu Shan, Jie Shi, Bo Yuan, Lei Wang, Xia Yang   +11 more
wiley   +1 more source

Hemodynamic Alterations of Acute Pulmonary Thromboembolism [PDF]

, 1962
Loren F. Parmley, Robert L. North, B. Ott   +2 more
openalex   +1 more source

Gout in pregnancy: Obstetric and neonatal outcomes

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.
Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar, Ahmad Badeghiesh, Haitham Baghlaf, Michael H. Dahan   +3 more
wiley   +1 more source

Preventing postoperative thromboembolism. [PDF]

, 1979
C. R. M. Prentice, Gordon Lowe, C.D. Forbes   +2 more
  +8 more sources

COVID-19 and its implication for venous thromboembolism

Cardiology Journal, 2020
Michał Ciurzynski, Justyna Domienik-Karłowicz, Miłosz Jaguszewski, Piotr Pruszczyk   +3 more
doaj   +1 more source